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Specific cell surface markers on mesenchymal stem/progenitor cells (MSCs) in vivo were poorly defined. Recently, it has, however, been 
demonstrated that a MSC subpopulation is directly isolated from CD271-positive fraction of human bone marrow cells (BMCs). The aim of this study 
is to (1) investigate whether circulating CD271(+) MSCs are mobilized into human peripheral blood after acute myocardial infarction (MI) and (2) 
examine a proangiogenic potential of CD271(+)-sorted MSCs from human BM. 
Methods and Results: In flow cytometric analysis, around 8% of CD34(+) cells in human BM was co-positive for CD271. Circulating CD34(+)
CD271(+) cells were identified in human peripheral blood, and the percentage of CD271(+) cells in the CD34(+) cells was positively associated with 
the age in the subjects without coronary artery disease (n=37, mean 2.8 (2.0) %, r2=0.13, p< 0.05). Number of the circulating CD271(+) MSCs in 
the patients with acute MI on admission (23.8 (5.7) cells/ml, n= 16) was somewhat higher than in the patients with stable coronary artery disease 
(9.7 (2.2) cells/ml, n= 8). After acute MI, the levels of circulating MSCs peaked at day 3 (35.5 (6.0) cells/ml) and decreased again at day 7 (12.2 
(4.0) cells/ml, p<0.05 vs. day 3). The MSC counts at day 3 were positively correlated with the peak concentrations of creatine kinase (r2= 0.72, 
p<0.01). In an experimental study, MSCs isolated from the CD271 fraction of BMCs readily generated single cell-derived colonies, had a fibroblastic 
spindle-like shape typical of MSCs, and differentiated into endothelial-like and vascular smooth muscle-like cells when exposed to the appropriate 
differentiation media. Conditioned medium from the CD271(+)-sorted MSCs contained several angiogenic factors such as VEGF, HGF, SDF-1 and 
adrenomedulin. The conditioned medium promoted differentiation of resident cardiac progenitor cells to vascular cell lineages in vitro. 
Conclusions: Mobilization of the circulating CD271(+) MSCs raises the possibility that the cells may play a role in cardiac repair after acute injury. 
MSCs from CD271 fraction of BMCs possess properties that make them attractive for use in angiogenic cell therapies.
